SignatureFD’s Indivior Pharmaceuticals INDV Stock Holding History

SignatureFD’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9K	Buy	+363	New	+$13.2K	﹤0.01%	2473

Other funds holding INDV

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

SignatureFD's INDV Position: Q2 2026 in Review

SignatureFD opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 363 shares worth $14.9K. The stake represents ﹤0.01% of the portfolio and ranks #2473 among its holdings.

49 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

SignatureFD held 363 shares of Indivior Pharmaceuticals worth $14.9K as of Q2 2026.
Indivior Pharmaceuticals was a new SignatureFD position in Q2 2026.
Indivior Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2473 holding.
49 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.